rs77899976

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_025265.4(TSEN2):​c.327G>A​(p.Glu109Glu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0181 in 1,614,160 control chromosomes in the GnomAD database, including 503 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.025 ( 66 hom., cov: 32)
Exomes 𝑓: 0.017 ( 437 hom. )

Consequence

TSEN2
NM_025265.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.600

Publications

7 publications found
Variant links:
Genes affected
TSEN2 (HGNC:28422): (tRNA splicing endonuclease subunit 2) This gene encodes one of the subunits of the tRNA splicing endonuclease. This endonuclease catalyzes the first step in RNA splicing which is the removal of introns. Mutations in this gene have been associated with pontocerebellar hypoplasia type 2. A pseudogene has been identified on chromosome 4. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Feb 2009]
TSEN2 Gene-Disease associations (from GenCC):
  • pontocerebellar hypoplasia type 2B
    Inheritance: AR Classification: STRONG Submitted by: PanelApp Australia, G2P, Labcorp Genetics (formerly Invitae)
  • pontocerebellar hypoplasia type 2
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 3-12503280-G-A is Benign according to our data. Variant chr3-12503280-G-A is described in ClinVar as Benign. ClinVar VariationId is 137749.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.6 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.0538 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TSEN2NM_025265.4 linkc.327G>A p.Glu109Glu synonymous_variant Exon 5 of 12 ENST00000284995.11 NP_079541.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TSEN2ENST00000284995.11 linkc.327G>A p.Glu109Glu synonymous_variant Exon 5 of 12 1 NM_025265.4 ENSP00000284995.6

Frequencies

GnomAD3 genomes
AF:
0.0245
AC:
3728
AN:
152176
Hom.:
63
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0333
Gnomad AMI
AF:
0.00439
Gnomad AMR
AF:
0.0472
Gnomad ASJ
AF:
0.00259
Gnomad EAS
AF:
0.0375
Gnomad SAS
AF:
0.0600
Gnomad FIN
AF:
0.0107
Gnomad MID
AF:
0.0158
Gnomad NFE
AF:
0.0137
Gnomad OTH
AF:
0.0364
GnomAD2 exomes
AF:
0.0245
AC:
6152
AN:
250798
AF XY:
0.0249
show subpopulations
Gnomad AFR exome
AF:
0.0316
Gnomad AMR exome
AF:
0.0359
Gnomad ASJ exome
AF:
0.00397
Gnomad EAS exome
AF:
0.0338
Gnomad FIN exome
AF:
0.00970
Gnomad NFE exome
AF:
0.0143
Gnomad OTH exome
AF:
0.0235
GnomAD4 exome
AF:
0.0175
AC:
25532
AN:
1461866
Hom.:
437
Cov.:
31
AF XY:
0.0182
AC XY:
13223
AN XY:
727236
show subpopulations
African (AFR)
AF:
0.0314
AC:
1050
AN:
33480
American (AMR)
AF:
0.0388
AC:
1735
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00344
AC:
90
AN:
26136
East Asian (EAS)
AF:
0.0436
AC:
1729
AN:
39700
South Asian (SAS)
AF:
0.0554
AC:
4775
AN:
86256
European-Finnish (FIN)
AF:
0.0102
AC:
547
AN:
53420
Middle Eastern (MID)
AF:
0.0127
AC:
73
AN:
5766
European-Non Finnish (NFE)
AF:
0.0129
AC:
14327
AN:
1111992
Other (OTH)
AF:
0.0200
AC:
1206
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.463
Heterozygous variant carriers
0
1419
2837
4256
5674
7093
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
640
1280
1920
2560
3200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0245
AC:
3738
AN:
152294
Hom.:
66
Cov.:
32
AF XY:
0.0261
AC XY:
1943
AN XY:
74470
show subpopulations
African (AFR)
AF:
0.0333
AC:
1385
AN:
41556
American (AMR)
AF:
0.0472
AC:
722
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00259
AC:
9
AN:
3472
East Asian (EAS)
AF:
0.0378
AC:
196
AN:
5184
South Asian (SAS)
AF:
0.0594
AC:
287
AN:
4830
European-Finnish (FIN)
AF:
0.0107
AC:
113
AN:
10610
Middle Eastern (MID)
AF:
0.0170
AC:
5
AN:
294
European-Non Finnish (NFE)
AF:
0.0137
AC:
934
AN:
68030
Other (OTH)
AF:
0.0394
AC:
83
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
183
366
548
731
914
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
46
92
138
184
230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0168
Hom.:
103
Bravo
AF:
0.0258
Asia WGS
AF:
0.0910
AC:
316
AN:
3478
EpiCase
AF:
0.0146
EpiControl
AF:
0.0158

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Feb 08, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 04, 2014
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Pontoneocerebellar hypoplasia Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
0.14
DANN
Benign
0.79
PhyloP100
-0.60
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs77899976; hg19: chr3-12544779; COSMIC: COSV53191635; COSMIC: COSV53191635; API